Quick10K

⚲

Cell Medx

Filings

10-Q	2020-11-30	Filed 2021-01-14
10-Q	2020-08-31	Filed 2020-10-15
10-K	2020-05-31	Filed 2020-09-15
10-Q	2020-02-29	Filed 2020-04-14
10-Q	2019-11-30	Filed 2020-01-14
10-Q	2019-08-31	Filed 2019-10-15
10-K	2019-05-31	Filed 2019-09-06
10-Q	2019-02-28	Filed 2019-04-22
10-Q	2018-11-30	Filed 2019-01-14
10-Q	2018-08-31	Filed 2018-10-15
10-K	2018-05-31	Filed 2018-09-13
10-Q	2018-02-28	Filed 2018-04-16
10-Q	2017-11-30	Filed 2018-01-16
10-Q	2017-08-31	Filed 2017-10-17
10-K	2017-05-31	Filed 2017-08-29
10-Q	2017-02-28	Filed 2017-04-14
10-Q	2016-11-30	Filed 2017-01-17
10-Q	2016-08-31	Filed 2016-10-17
10-K	2016-05-31	Filed 2016-09-13
10-Q	2016-02-29	Filed 2016-04-14
10-Q	2015-11-30	Filed 2016-01-14
10-Q	2015-08-31	Filed 2015-10-15
10-K	2015-05-31	Filed 2015-09-03
10-Q	2015-02-28	Filed 2015-04-14
10-Q	2014-11-30	Filed 2015-01-14
10-Q	2014-08-31	Filed 2014-10-09
10-K	2014-05-31	Filed 2014-08-26
10-Q	2014-02-28	Filed 2014-04-18
10-Q	2013-11-30	Filed 2014-01-13
10-Q	2013-08-31	Filed 2013-10-03
10-Q	2013-02-28	Filed 2013-04-15
10-Q	2012-11-30	Filed 2013-01-16
10-Q	2012-08-31	Filed 2012-10-15
10-K	2012-05-31	Filed 2012-10-11
10-Q	2012-02-29	Filed 2012-04-09
10-Q	2011-11-30	Filed 2012-03-02
10-Q	2011-08-31	Filed 2011-10-17
10-K	2011-05-31	Filed 2011-09-21

Reports

8-K	2020-07-30
8-K	2020-06-08
8-K	2020-05-06
8-K	2020-01-29
8-K	2019-06-24
8-K	2019-03-21
8-K	2018-12-27
8-K	2018-05-07
8-K	2018-03-23

Cell Medx Financials

CMXC Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash	0	0	30	24	24	19	13	11	5	2	1	1	0	0	29	1	7	2	15	28	38	118	9	67	326	108	24	8	24	131	57
Accounts Receivable
Inventory															1	1	1	1	1	5	1	4	3	8	22	29	30	11	60	64	73
PP&E																28	26	35	32	207	207	207	256	194	154	116	79		2	1	1
Assets	0	0	30	24	24	19	13	11	5	2				105	59	47	45	48	167	269	252	379	335	294	532	376	163	45	95	222	191
Accounts Payable						0	0		0	0	0	2	40	159	186	220	256	302	326	384	404	397	453	448	486	515	544	595	669	706	734
Long-Term Debt
Liabilities	7	13	17	13	13	13	13	13	13	13				393	580	731	943	1,115	1,367	1,681	1,895	880	1,107	1,463	1,563	982	1,001	1,119	1,532	1,860	1,963
Stockholders' Equity	-7	-13	13	11	11	6	-0	-2	-8	-11	-15	-20	-68	-288	-521	-684	-899	-1,067	-1,201	-1,413	-1,642	-502	-772	-1,169	-1,031	-605	-839	-1,073	-1,437	-1,638


Income Statement ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Revenue	0	0	0	0	0	0	0	0	0	0	0	0			5								1	0
Cost of Revenue															-2								0	0
Gross Profit															3	13	1	1	1	5	2	0	0	0
R&D															146	32	554	25	16	56	73	67	53	104	48	41	111	218	34	64	15
SG&A	0	5	3	1	0	5	6	2	6	3	4	5	48		70	52	73	59	42	68	44	51	121	183	54	34	80	67	24	36	57
Tax
Net Income	-4	-6	-4	-2	0	-1	-6	-2	-6	-2	-4	-5	-48	-273	-419	-292	-1,029	-480	-296	-334	-279	-1,060	-305	394	-833	-181	-296	-236	-128	-391	-144


Cash Flow ($'000)	2011-08-31	2011-11-30	2012-02-29	2012-05-31	2012-08-31	2012-11-30	2013-02-28	2013-05-31	2013-08-31	2013-11-30	2014-02-28	2014-05-31	2014-08-31	2014-11-30	2015-02-28	2015-05-31	2015-08-31	2015-11-30	2016-02-29	2016-05-31	2016-08-31	2016-11-30	2017-02-28	2017-05-31	2017-08-31	2017-11-30	2018-02-28	2018-05-31	2018-11-30	2019-02-28	2019-05-31
Cash Operating	-2	-9	0	-7	0	-5	-6	-2	-6	-3	-1	0	-1	-20	-203	-92	-98	-65	-175	-84	-123	-280	-157	-194	-108	-225	-85	-31		-142
Cash Investing	0	0	0	0	0	0	0	0	0	0	0	0			86	-9	-19	-14	-1	-185	-15	0	-95	0						0	0
Cash Financing	2	9	30	1	0	0	0	0	0	0	0	0			145	75	122	74	186	285	149	360	142	254	366	6	0	16		250	33